Partnerships

Human BioSciences, Inc. (“HBS”) has been designing, manufacturing, distributing, and marketing advanced collagen-based wound care products for over thirty years. SkinTemp II and Medifil II are examples of HBS’s ability to convert laboratory concepts into exceptional, marketable advanced wound care products. HBS’s proprietary, FDA cleared and Medicare reimbursable KollagenTM products are revolutionizing the wound care industry by reducing healing times, treatment costs, amputation rates, and wound recurrence while increasing quality of life.Footnote needed – show some research results
Partnerships and Joint Ventures are a key part of our mission to help heal wounds. WE SEEK NEW PARTNERS TO GROW WITH US!

UNITED STATES:

In addition to supplying the market with our own branded products, we are the largest and lowest cost OEM of collagen wound care products in the US. HBS has an economical supply of premium raw materials and is vertically integrated, allowing usit to offer and pass along amazing savings to ourits partners. We supply many of the largest brands on the markett. We and are now seeking additional distribution partners that wish to benefit from our top quality product, long history of reliability and market leading production efficiencies.
If you are interested in discussing distribution partnerships or our OEM capabilities and pricing, please contact Henry Hall, Head of Corporate Development, at henry@humanbiosciences.com

INTERNATIONAL:

HBS is perfectly positioned to offer an attractive Joint Venture opportunity to potential partners. Armed with a streamlined supply chain, proprietary manufacturing systems, life-changing products and a strong local partner, we can create an unmatched competitive turn-key wound care device manufacturing firm in any country.
HBS is ISO certified and has established manufacturing and quality assurance systems which are regularly audited by the FDA. HBS’s KollagenTM products are all FDA approved through a 510(k) process.
Along with providing its technical knowledge and product expertise, HBS is a full partner in the JV. We provide support at every step along the way to mitigate risk and ensure successful returns. Our participation includes:

INTERNATIONAL:

Along with its proprietary ingredients, HBS can supply its JVs with the highest quality raw material in the collagen-based wound care industry at the market’s lowest price. HBS has an economical supply of premium raw material and is vertically integrated, allowing it to offer and pass along amazing savings to its partners. Decades of experience guarantee a smooth knowledge-transfer and continued support to JV partners.

Financing:

HBS can provide financing on attractive terms for all equipment purchases.

Offtake Agreement:

HBS will commit to providing the option to purchase a certain amount of the joint venture facility’s unfinished products on concrete financial terms for a definable period. This limits start-up risk and guarantees an earlier break-even point for the joint venture company.

Turnkey Manufacturing Operation:

HBS will help the joint venture company purchase all equipment and controls necessary to process, manufacture, inspect and package products as per HBS’s established procedures. The equipment shall conform to HBS’s proprietary designs and shall be similar to or improved from the equipment HBS uses in its own factories.

Assistance in Obtaining Product Approval:

HBS will support the JV in the preparation of regulatory approval documents in accordance with national and international standards. Further, if local regulations allow, HBS will provide the joint venture company with all data necessary to use HBS’s approval in the USA as a basis for approval in the joint venture country. HBS will also continue to provide its expertise throughout the regulatory process.

Assistance with Land and Building Site Selection:

Harnessing and scaling KollagenTM technology requires facilities that can adhere to the strictest manufacturing and environmental controls. Accordingly, HBS will assist the JV in the selection of the location and factory specifications.

Current Joint Ventures:

Taiwan

HBS has a successful joint venture with Taiyen Biotech, a public-sector organization in Taiwan. The 16-year old partnership between HBS with CTCI Corporation (中鼎集團) and Taiyen Biotech, formerly under Taiwan Salt Industrial Corporation (TSIC), is a testament to the global applicability of HBS’s R&D capabilities. HBS assisted Taiyen Biotech by supplying KollagenTM technology, building the plant & machinery and setting up quality assurance protocols on a turnkey basis.

India

Human BioSciences India Ltd. (“HBS India”) is a subsidiary of HBS which began operations in 2011. HBS India has a state-of-the-art manufacturing facility, as well as an ultra-modern lab for new product development and contract research, in Ahmedabad, Gujarat. We are partnering with major medical distributors to leverage several unique technologies developed and manufactured in India.
If you are interested in discussing international joint venture or distribution partnerships please contact Henry Hall, Head of Corporate Development, at henry@humanbiosciences.com or Dr.Gerhard Goebel, International Business Development, at g.goebel@humanbiosciences.com